Table A3.

No. of Patients With [¹⁸F]FDG-PET/CT Scan Data by Time Point and Cohort

Time Point	Cohort 1	Cohort 2	Total
Baseline	39	44	83
Week 1	39	43	82
Week 8	34	42	76
Week 1 and week 8	34	41	75

NOTE. Eighty-seven patients were enrolled onto the trial (cohort 1, 41; cohort 2, 46). Per protocol, patients underwent [¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography ([¹⁸F]FDG-PET/CT) scans at baseline, week 1, and week 8. One patient who did not start protocol therapy and one patient who did not have metastatic breast cancer were excluded from all [¹⁸F]FDG-PET/CT analyses.